Gene: APOA1

335
apo(a)
apolipoprotein A1
protein-coding
11q23.3
Ensembl:ENSG00000118137 MIM:107680 Vega:OTTHUMG00000046112 UniprotKB:P02647
NG_012021.1
PubMed
ND
76   
NA (AD)  NA (ND)   (Frontal_Cortex)
4.506e-2 (AD)  2.763e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
AGXT0.545
FGA0.533
FGB0.513
BCL7C0.51
FGG0.497
CRP0.494
MPST0.484
APOC30.477
APCS0.476
SERF20.473

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MED12L-0.421
MKL2-0.411
NFAT5-0.409
CLCN5-0.405
NCR3LG1-0.396
HIVEP1-0.394
MROH1-0.39
RAPH1-0.39
PCDHGC4-0.386
ZNF629-0.385

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB01593ZincSmall Molecule7440-66-6Approved|InvestigationalTarget
DB09130CopperSmall Molecule7440-50-8Approved|InvestigationalTarget
ID Drug Name Action PubMed
C0024481,2-linoleoylphosphatidylcholine"1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein"19717637
C0024481,2-linoleoylphosphatidylcholine"Glyburide promotes the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C0024481,2-linoleoylphosphatidylcholine"N-acetylleucyl-leucyl-norleucine inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C0024481,2-linoleoylphosphatidylcholine"resveratrol inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C0024481,2-linoleoylphosphatidylcholine"TO-901317 inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C0602291-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]"19013290
C0620781-(carboxymethylthio)tetradecane1-(carboxymethylthio)tetradecane results in decreased expression of APOA1 mRNA7983038
C0382371-oleoyl-2-acetylglycerol1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
C0297902,2',3',4,4',5-hexachlorobiphenyl"2,2',3',4,4',5-hexachlorobiphenyl affects the expression of APOA1 mRNA"21703328
C0467282,2'-azobis(2-amidinopropane)"2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein"12576517
C0467282,2'-azobis(2-amidinopropane)"[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
C0467282,2'-azobis(2-amidinopropane)"Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
C0467282,2'-azobis(2-amidinopropane)"Pentetic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
C0164032,4-dinitrotoluene"2,4-dinitrotoluene results in decreased expression of APOA1 mRNA"16917068
C04456324-hydroxycholesterol24-hydroxycholesterol promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
C04456324-hydroxycholesterol24-hydroxycholesterol results in increased secretion of APOA1 protein16530456
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of APOA1 mRNA"21346803
C07699627-hydroxycholesterol27-hydroxycholesterol promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
C07699627-hydroxycholesterol27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]]20083572
C0227762-bromopalmitate2-bromopalmitate results in decreased expression of APOA1 mRNA7556148
C4574992-chloro-5-nitrobenzanilide2-chloro-5-nitrobenzanilide inhibits the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]19797938
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of APOA1 mRNA"23644946
C5756314-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile"4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile affects the expression of APOA1 mRNA"21218783
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA"27188386
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal binds to APOA1 protein18778096
C0415944-nonylphenol4-nonylphenol affects the expression of APOA1 mRNA15792627
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA"27188386
C4187629,12-dioxo-10-dodecenoic acid"9,12-dioxo-10-dodecenoic acid binds to APOA1 protein"18778096
C0371129-deoxy-delta-9-prostaglandin D2[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]12595494
C1190069-hydroxy-12-oxo-10(E)-dodecenoic acid9-hydroxy-12-oxo-10(E)-dodecenoic acid binds to APOA1 protein18778096
C5705259-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine"9-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine analog results in increased expression of APOA1 protein"25278768
C5705259-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine"9-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine results in increased expression of APOA1 protein"25278768
D000082AcetaminophenAcetaminophen results in decreased expression of APOA1 mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of APOA1 mRNA17562736
D000082Acetaminophen[CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of APOA1 protein25499718
D000082AcetaminophenAcetaminophen affects the expression of APOA1 protein16099942
D000171AcroleinAcrolein affects the metabolism of APOA1 protein16037261|1612672
D000171Acrolein[Acrolein affects the metabolism of APOA1 protein] which results in decreased secretion of Cholesterol16126721
D000171AcroleinAcrolein inhibits the reaction [APOA1 protein affects the transport of Cholesterol]16037261
C038518acrylodanacrylodan binds to APOA1 protein11087425
D016604Aflatoxin B1Aflatoxin B1 affects the expression of APOA1 protein20106945
C103303alitretinoinalitretinoin results in increased expression of APOA1 protein9869165
D024502alpha-Tocopherolalpha-Tocopherol results in decreased expression of APOA1 mRNA16423621
D024502alpha-Tocopherolalpha-Tocopherol results in decreased expression of APOA1 protein16423621
D024502alpha-Tocopherolalpha-Tocopherol results in decreased activity of APOA1 promoter16423621
D006710HomocysteineHomocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 mRNA]18540024
D006710HomocysteineHomocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 protein]18540024
D006710HomocysteineHomocysteine results in decreased expression of APOA1 mRNA18540024
D006710HomocysteineHomocysteine results in decreased expression of APOA1 protein18540024
C059765amphotericin B, deoxycholate drug combination"amphotericin B, deoxycholate drug combination results in decreased expression of APOA1 mRNA"22863853
D016718Arachidonic AcidArachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D016718Arachidonic AcidArachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
D016718Arachidonic AcidArachidonic Acid results in decreased expression of APOA1 mRNA7983038
D001205Ascorbic AcidAscorbic Acid results in decreased expression of APOA1 mRNA16423621
D001205Ascorbic AcidAscorbic Acid results in decreased expression of APOA1 protein16423621
D001205Ascorbic AcidAscorbic Acid results in decreased activity of APOA1 promoter16423621
D001241AspirinAspirin results in increased expression of APOA1 mRNA18519978|9399670
D001241AspirinAHR mutant form inhibits the reaction [Aspirin results in increased expression of APOA1 mRNA]18519978
D001241AspirinAspirin promotes the reaction [APOA1 affects the transport of Cholesterol]21088444
D001241AspirinAspirin results in increased expression of APOA1 mRNA18519978
D001241AspirinPPARA affects the reaction [Aspirin promotes the reaction [APOA1 affects the transport of Cholesterol]]21088444
D001241AspirinAspirin results in increased activity of APOA1 mRNA18519978
D001262AtenololAtenolol results in decreased expression of APOA1 protein2193493
D001280Atrazine[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of APOA1 mRNA16532367
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of APOA1 mRNA22727790
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of APOA1 protein22727790
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of APOA1 mRNA22228805
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of APOA1 mRNA20440473
D001629Bezafibrate[Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]12595494
D001629BezafibrateBezafibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D001629BezafibrateBezafibrate results in decreased expression of APOA1 mRNA7983038
D001629BezafibrateBezafibrate results in decreased expression of APOA1 protein10751747
D001629BezafibrateBezafibrate results in increased expression of APOA1 protein1323073|7893284|
D001629BezafibrateBezafibrate results in increased expression of APOA1 protein9869165
D001629BezafibrateBezafibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D001629BezafibrateBezafibrate results in increased expression of APOA1 mRNA16530456
D001629BezafibrateBezafibrate results in increased secretion of APOA1 protein16530456
C532858biotinylated linoleoylglycerylphosphatidylcholinebiotinylated linoleoylglycerylphosphatidylcholine binds to APOA1 protein18778096
C006780bisphenol Abisphenol A results in decreased expression of APOA1 mRNA16835292|1791269
C006780bisphenol Abisphenol A results in decreased expression of APOA1 mRNA27502578
C006780bisphenol Abisphenol A results in increased expression of APOA1 mRNA18418863
C006780bisphenol Abisphenol A results in increased expression of APOA1 protein18418863|2293844
C006780bisphenol Abisphenol A results in increased expression of APOA1 mRNA27104808
C006780bisphenol Abisphenol A results in decreased expression of APOA1 mRNA28079927
C006780bisphenol A[bisphenol A co-treated with Fructose] results in increased expression of APOA1 protein23142792
C006780bisphenol Abisphenol A results in decreased expression of APOA1 mRNA25181051
C006780bisphenol Abisphenol A results in increased expression of APOA1 protein22649256
C006780bisphenol Abisphenol A results in increased methylation of APOA1 gene28505145
C053342brevetoxinbrevetoxin analog results in decreased expression of APOA1 mRNA14529743
D002079Butter"[Butter co-treated with Cholesterol, Dietary] results in increased expression of APOA1 protein"15735083
D002084Butylated Hydroxytoluene"[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
D002084Butylated Hydroxytoluene"Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of APOA1 mRNA18804290
D002104CadmiumAPOA1 protein binds to Cadmium23896426
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of APOA1 protein26220685
D019256Cadmium ChlorideCadmium Chloride affects the expression of APOA1 mRNA22110744
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of APOA1 protein22081424
C037123cadmium sulfatecadmium sulfate results in decreased expression of APOA1 mRNA20596552
D002110Caffeine[Ephedrine co-treated with Caffeine] results in increased expression of APOA1 protein16324916
D002110CaffeineCaffeine results in decreased expression of APOA1 mRNA25868845
D000074262Canola Oil"[Canola Oil co-treated with Cholesterol, Dietary] results in decreased expression of APOA1 protein"15735083
D000074262Canola OilCanola Oil affects the expression of APOA1 mRNA16177195
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of APOA1 mRNA15816358|9059516
D002251Carbon TetrachlorideDinoprostone inhibits the reaction [Carbon Tetrachloride results in increased expression of APOA1 mRNA]15816358
D002586CesiumCesium results in decreased expression of APOA1 mRNA20173315
D002635Chenodeoxycholic AcidChenodeoxycholic Acid results in decreased expression of APOA1 protein19445040
D007631ChlordeconeChlordecone affects the localization of APOA1 protein18789348
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of APOA1 mRNA18804290
D002784Cholesterol1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D002784Cholesterol[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]12595494
D002784Cholesterol[Acrolein affects the metabolism of APOA1 protein] which results in decreased secretion of Cholesterol16126721
D002784CholesterolAcrolein inhibits the reaction [APOA1 protein affects the transport of Cholesterol]16037261
D002784CholesterolAPOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]16118212
D002784CholesterolAPOA1 protein promotes the reaction [ABCA1 protein results in increased export of Cholesterol]15983222
D002784CholesterolAPOA1 protein results in increased export of Cholesterol23041272
D002784CholesterolAPOA1 protein results in increased secretion of Cholesterol12531903|2005692
D002784CholesterolArachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D002784Cholesterol[Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]12595494
D002784CholesterolCYP27A1 protein promotes the reaction [APOA1 protein results in increased secretion of Cholesterol]12531903
D002784CholesterolFingolimod Hydrochloride promotes the reaction [APOA1 protein results in increased secretion of Cholesterol]20056921
D002784CholesterolLinoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D002784Cholesterolmastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]16118212
D002784CholesterolOleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D002784Cholesterolpalmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D002784Cholesterol[pirinixic acid binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]12595494
D002784CholesterolPLD2 protein affects the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]16118212
D002784CholesterolPLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]]16118212
D002784Cholesterolresveratrol inhibits the reaction [APOA1 protein results in increased export of Cholesterol]23041272
D002784Cholesterol27-hydroxycholesterol promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D002784Cholesterol27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]]20083572
D002784Cholesterol2-chloro-5-nitrobenzanilide inhibits the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]19797938
D002784CholesterolAPOA1 affects the transport of Cholesterol21088444
D002784CholesterolAPOA1 protein results in increased export of Cholesterol19797938|2520442
D002784CholesterolAspirin promotes the reaction [APOA1 affects the transport of Cholesterol]21088444
D002784Cholesterol[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol20083572
D002784CholesterolCholesterol results in decreased expression of APOA1 protein16115471
D002784Cholesterol[Glutathione co-treated with Quercetin] promotes the reaction [APOA1 protein results in increased export of Cholesterol]25204422
D002784CholesterolNiacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]19797938
D002784CholesterolPPARA affects the reaction [Aspirin promotes the reaction [APOA1 affects the transport of Cholesterol]]21088444
D002784CholesterolPPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]19797938
D002784CholesterolProbucol inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D002784CholesterolProbucol inhibits the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]]20083572
D002784CholesterolQuercetin promotes the reaction [APOA1 protein results in increased export of Cholesterol]25204422
D002784CholesterolSTAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D002784Cholesterol[TO-901317 co-treated with APOA1 protein] results in increased secretion of Cholesterol20083572
D002784CholesterolTO-901317 promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D002784Cholesterol[Ethanol co-treated with APOA1 protein] results in decreased abundance of Cholesterol17478430
D002784Cholesterol24-hydroxycholesterol promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D002784CholesterolAPOA1 protein results in increased transport of Cholesterol16530456
D002784CholesterolFenofibrate inhibits the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D002784CholesterolFenofibrate promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D002784Cholesterolpioglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D002784CholesterolTO-901317 promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D002784Cholesteroltroglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D002784CholesterolAPOA1 protein results in increased transport of Cholesterol12595494
D002791Cholesterol, Dietary"[Butter co-treated with Cholesterol, Dietary] results in increased expression of APOA1 protein"15735083
D002791Cholesterol, Dietary"[Canola Oil co-treated with Cholesterol, Dietary] results in decreased expression of APOA1 protein"15735083
D002791Cholesterol, Dietary"[Coconut Oil co-treated with Cholesterol, Dietary] results in increased expression of APOA1 protein"15735083
D002791Cholesterol, Dietary"[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APOA1 mRNA"19509184
D002791Cholesterol, Dietary"[Margarine co-treated with Cholesterol, Dietary] results in decreased expression of APOA1 protein"15735083
D002791Cholesterol, Dietary"[Soybean Oil co-treated with Cholesterol, Dietary] results in decreased expression of APOA1 protein"15735083
D008076Cholesterol, HDL"Fatty Acids, Unsaturated affects the reaction [APOA1 promoter SNP affects the abundance of Cholesterol, HDL]"11756058
D008076Cholesterol, HDL"PON1 protein binds to [APOA1 protein binds to Cholesterol, HDL]"16128586
D008076Cholesterol, HDL"APOA1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Cholesterol, HDL]"20972769
D008076Cholesterol, HDL"APOA1 protein results in increased abundance of Cholesterol, HDL"20972769
D008076Cholesterol, HDL"APOA1 protein results in increased abundance of Cholesterol, HDL"18332268
D008076Cholesterol, HDL"APOA1 protein results in increased abundance of Cholesterol, HDL"16511610
D008076Cholesterol, HDL"[[Fibric Acids results in increased expression of APOA1] co-treated with [Fibric Acids results in increased expression of APOA2]] results in increased abundance of Cholesterol, HDL"11123853
D002857Chromium[Chromium co-treated with Niacin] results in increased expression of APOA1 mRNA18602814
D002857ChromiumChromium results in increased expression of APOA1 mRNA18602814
C074702chromium hexavalent ionchromium hexavalent ion affects the expression of APOA1 mRNA28472532
C041167chromium nitratechromium nitrate results in decreased expression of APOA1 protein23618972
C017133chromous chloridechromous chloride affects the expression of APOA1 mRNA12679171
C553724ciklavitciklavit inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]23287313
C019304ciprofibrateciprofibrate results in decreased expression of APOA1 mRNA7983038
C019304ciprofibrateciprofibrate results in increased expression of APOA1 mRNA9869165
C019304ciprofibrateciprofibrate results in increased expression of APOA1 protein9869165
D002994ClofibrateClofibrate results in increased secretion of APOA1 protein19717637
D002994ClofibrateGlyburide promotes the reaction [Clofibrate results in increased secretion of APOA1 protein]19717637
D002994ClofibrateClofibrate results in decreased expression of APOA1 mRNA16081524
D002994ClofibrateClofibrate results in increased expression of APOA1 protein9869165
D002994ClofibrateClofibrate results in decreased expression of APOA1 mRNA11328961|1285110
D002995Clofibric AcidClofibric Acid results in increased expression of APOA1 protein9869165
D003000ClonidineClonidine results in decreased expression of APOA1 protein2193493
C018021cobaltous chloridecobaltous chloride results in decreased expression of APOA1 mRNA24386269
D000074263Coconut Oil"[Coconut Oil co-treated with Cholesterol, Dietary] results in increased expression of APOA1 protein"15735083
D003300CopperCopper results in increased expression of APOA1 protein22480594
D003300CopperAPOA1 protein binds to Copper23896426
D003300CopperCopper deficiency results in increased expression of APOA1 protein18993053
D019327Copper SulfateCopper Sulfate results in decreased expression of APOA1 mRNA19549813
C057862cyanoginosin LRcyanoginosin LR results in increased expression of APOA1 protein26984711
D016572CyclosporineCyclosporine results in decreased expression of APOA1 mRNA20106945|2556210
D016572CyclosporineCyclosporine results in increased expression of APOA1 mRNA21163907
D016572CyclosporineCyclosporine results in increased secretion of APOA1 protein21354196
C017160cypermethrincypermethrin results in increased expression of APOA1 mRNA9650644
D017373Cyproterone AcetateCyproterone Acetate affects the expression of APOA1 protein16323982
D003687DehydroepiandrosteroneDehydroepiandrosterone results in decreased expression of APOA1 mRNA18709148
D003907DexamethasoneDexamethasone affects the expression of APOA1 mRNA15102944
D003907DexamethasoneDexamethasone results in increased expression of APOA1 mRNA11328961|7556148
D003907Dexamethasone[fenofibric acid co-treated with Dexamethasone] results in increased expression of APOA1 mRNA7556148
D003907Dexamethasonefenofibric acid inhibits the reaction [Dexamethasone results in increased expression of APOA1 mRNA]7556148
D003994Bucladesine27-hydroxycholesterol promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D003994Bucladesine27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]]20083572
D003994Bucladesine[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 mRNA20083572
D003994Bucladesine[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 protein23227865
D003994Bucladesine[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol20083572
D003994BucladesineOligomycins inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 protein]23227865
D003994BucladesineProbucol inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D003994BucladesineProbucol inhibits the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]]20083572
D003994BucladesineSTAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 mRNA]20083572
D003994BucladesineSTAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D003994BucladesineTO-901317 promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D004026DieldrinDieldrin results in increased expression of APOA1 mRNA23041725
D004041Dietary Fatsciklavit inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]23287313
D004041Dietary FatsDietary Fats results in decreased expression of APOA1 protein18166149|2328731
D004041Dietary FatsFenofibrate inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]18166149
D004041Dietary Fats"[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APOA1 mRNA"19509184
D004041Dietary Fatsgamma-sitosterol inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]23287313
D004041Dietary Fatsresveratrol inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]18166149
D004041Dietary FatsDietary Fats results in decreased expression of APOA1 mRNA25016146
D004041Dietary Fats[Oligosaccharides co-treated with Dietary Fats] results in increased expression of APOA1 protein28549616
D004052Diethylnitrosamine[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOA1 protein20935162
C007379diethyl phthalatediethyl phthalate results in increased degradation of APOA1 protein26423653
C042080diisodecyl phthalatediisodecyl phthalate results in increased expression of APOA1 mRNA25825955
D004121Dimethyl SulfoxideDimethyl Sulfoxide results in increased expression of APOA1 mRNA16423621
D004121Dimethyl SulfoxideDimethyl Sulfoxide results in increased expression of APOA1 protein16423621
D004121Dimethyl SulfoxideDimethyl Sulfoxide results in increased activity of APOA1 promoter16423621
C056213dioleoyl ethylene glycoldioleoyl ethylene glycol inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D004237Diuron[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of APOA1 mRNA16532367
D004281Docosahexaenoic AcidsDocosahexaenoic Acids results in decreased expression of APOA1 mRNA7556148
D004317DoxorubicinDoxorubicin results in increased expression of APOA1 protein6416889|8255516|
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]"16297877
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal results in increased expression of APOA1 mRNA"16297877
D004365Drugs, Chinese Herbal"PPARA protein affects the reaction [Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]]"16297877
D004365Drugs, Chinese Herbal"PPARA protein affects the reaction [Drugs, Chinese Herbal results in increased expression of APOA1 mRNA]"16297877
D015118Eicosapentaenoic AcidEicosapentaenoic Acid results in decreased expression of APOA1 mRNA7556148
D0151175,8,11,14-Eicosatetraynoic Acid"5,8,11,14-Eicosatetraynoic Acid results in increased expression of APOA1 protein"9869165
D004603Elements, Radioactive"Elements, Radioactive results in decreased expression of APOA1 mRNA"20173315
C070609EMD 53998EMD 53998 analog results in decreased expression of APOA1 mRNA24977338
D004809Ephedrine[Ephedrine co-treated with Caffeine] results in increased expression of APOA1 protein16324916
D000431Ethanol[Ethanol co-treated with APOA1 protein] results in decreased abundance of Cholesterol17478430
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of APOA1 mRNA16835292|1791269
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of APOA1 mRNA16872691|1760630
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOA1 mRNA17942748
D000069438Ezetimibe[Niacin co-treated with Ezetimibe co-treated with Simvastatin] results in increased expression of APOA1 protein20152243
D000069438EzetimibeNiacin promotes the reaction [[Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein]18420099
D000069438Ezetimibe[Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein18420099
D005231Fatty Acids, Unsaturated"Fatty Acids, Unsaturated affects the reaction [APOA1 promoter SNP affects the abundance of Cholesterol, HDL]"11756058
D011345FenofibrateFenofibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D011345FenofibrateFenofibrate results in decreased expression of APOA1 mRNA7983038
D011345FenofibrateFenofibrate results in decreased expression of APOA1 protein19445040
D011345FenofibratePPARA protein inhibits the reaction [Fenofibrate results in decreased expression of APOA1 mRNA]7983038
D011345FenofibrateFenofibrate inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]18166149
D011345FenofibrateFenofibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D011345FenofibratePPARA protein affects the reaction [Fenofibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]]19201410
D011345Fenofibrate[Fenofibrate co-treated with Pyrazinamide] results in increased expression of APOA1 mRNA27071702
D011345FenofibrateFenofibrate inhibits the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D011345FenofibrateFenofibrate promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
D011345FenofibrateFenofibrate results in decreased expression of APOA1 mRNA16530456
D011345FenofibrateFenofibrate results in increased secretion of APOA1 protein16530456
C006012fenofibric acidfenofibric acid results in increased expression of APOA1 protein9869165
C006012fenofibric acid[fenofibric acid co-treated with Dexamethasone] results in increased expression of APOA1 mRNA7556148
C006012fenofibric acid[fenofibric acid co-treated with Tretinoin] results in increased expression of APOA1 mRNA7556148
C006012fenofibric acidfenofibric acid inhibits the reaction [Dexamethasone results in increased expression of APOA1 mRNA]7556148
C006012fenofibric acidfenofibric acid inhibits the reaction [Tretinoin results in increased expression of APOA1 mRNA]7556148
C006012fenofibric acidfenofibric acid results in decreased expression of APOA1 mRNA7556148
D058607Fibric AcidsFibric Acids results in increased expression of APOA111123853
D058607Fibric Acids"[[Fibric Acids results in increased expression of APOA1] co-treated with [Fibric Acids results in increased expression of APOA2]] results in increased abundance of Cholesterol, HDL"11123853
D000068876Fingolimod HydrochlorideFingolimod Hydrochloride promotes the reaction [APOA1 protein results in increased secretion of Cholesterol]20056921
D005419FlavonoidsFlavonoids results in decreased expression of APOA1 mRNA18035473
D005485FlutamideFlutamide results in decreased expression of APOA1 mRNA16835292
D005492Folic Acid[APOE gene mutant form affects the susceptibility to Folic Acid] which results in increased expression of APOA1 protein17118406
D004397FonofosFonofos results in increased methylation of APOA1 promoter22847954
D005632Fructose"[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APOA1 mRNA"19509184
D005632FructoseFructose results in decreased expression of APOA1 protein27531227
D005632FructosePlant Preparations inhibits the reaction [Fructose results in decreased expression of APOA1 protein]27531227
D005632Fructose[bisphenol A co-treated with Fructose] results in increased expression of APOA1 protein23142792
D005632FructoseFructose results in increased expression of APOA1 mRNA9322794
D005632FructoseFructose results in increased expression of APOA1 protein9322794
C069837fullerene C60fullerene C60 results in decreased expression of APOA1 mRNA19167457
C069837fullerene C60fullerene C60 results in increased expression of APOA1 mRNA19167457
C070081fulvestrantfulvestrant inhibits the reaction [Quercetin results in increased secretion of APOA1 protein]24963805
C025473gamma-sitosterolgamma-sitosterol inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]23287313
D015248GemfibrozilGemfibrozil promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D015248GemfibrozilGemfibrozil results in increased expression of APOA1 protein11701466
D015248GemfibrozilGemfibrozil results in increased expression of APOA1 mRNA9869165
D015248GemfibrozilGemfibrozil results in increased expression of APOA1 protein9869165
D015248GemfibrozilGemfibrozil promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D019833GenisteinGenistein results in increased expression of APOA1 protein22649256
C055328ginsenoside Rfginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]16297877
C055328ginsenoside Rfginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein]16297877
C055328ginsenoside Rfginsenoside Rf results in decreased expression of APOA1 protein16297877
C055328ginsenoside RfPPARA protein affects the reaction [ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]]16297877
D036145GinsenosidesGinsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]16297877
D036145GinsenosidesGinsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein]16297877
D036145GinsenosidesGinsenosides results in decreased expression of APOA1 protein16297877
D036145GinsenosidesGinsenosides results in increased expression of APOA1 mRNA16297877
D036145GinsenosidesPPARA protein affects the reaction [Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]]16297877
D036145GinsenosidesPPARA protein affects the reaction [Ginsenosides results in increased expression of APOA1 mRNA]16297877
D005944GlucosamineGlucosamine results in increased secretion of APOA1 protein15164326
D005944GlucosamineGlucosamine results in increased stability of APOA1 mRNA15164326
D005944GlucosamineGlucosamine results in increased expression of APOA1 protein17682119
D005944GlucosamineGlucosamine results in increased stability of APOA1 mRNA17682119
D005947GlucoseGlucose results in decreased expression of APOA1 mRNA9668074
D005947GlucoseGlucose results in increased expression of APOA1 mRNA9322794
D005947GlucoseGlucose results in increased expression of APOA1 protein9322794
D005978Glutathione[Glutathione co-treated with Quercetin] promotes the reaction [APOA1 protein results in increased export of Cholesterol]25204422
D005905Glyburide"Glyburide promotes the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
D005905GlyburideGlyburide promotes the reaction [Clofibrate results in increased secretion of APOA1 protein]19717637
D005990GlycerolGlycerol analog promotes the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
C004312glycidolglycidol results in decreased expression of APOA1 mRNA24915197
C010972glycolaldehydeglycolaldehyde inhibits the reaction [ABCA1 protein binds to APOA1 protein]15983222
D006037GlyoxalGlyoxal inhibits the reaction [ABCA1 protein binds to APOA1 protein]15983222
C010974glyphosateglyphosate results in increased expression of APOA1 mRNA16532367
C554645GSK525762AGSK525762A results in increased expression of APOA1 mRNA21568322
C554645GSK525762AGSK525762A results in increased expression of APOA1 protein21568322
C412815GW 4064GW 4064 results in decreased expression of APOA1 protein19445040
C425931GW 501516GW 501516 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
C425931GW 501516GW 501516 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
C453899GW 7647GW 7647 results in increased expression of APOA1 protein19445040
C020758indium trichlorideindium trichloride results in decreased expression of APOA1 protein19539025
C051140iron(II)-ascorbic acid complexiron(II)-ascorbic acid complex results in decreased expression of APOA1 protein10898742
C028904isoproturon[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of APOA1 mRNA16532367
C016527isoquercitrinisoquercitrin results in increased secretion of APOA1 protein24963805
C561695(+)-JQ1 compound(+)-JQ1 compound analog results in increased expression of APOA1 protein25278768
C561695(+)-JQ1 compound(+)-JQ1 compound results in increased expression of APOA1 protein25278768
C410337K 7174K 7174 results in decreased expression of APOA1 mRNA24086573
C099406L 742694L 742694 affects the expression of APOA1 mRNA15102944
D007854LeadAPOA1 protein binds to Lead23896426
D001556LindaneLindane results in decreased expression of APOA1 mRNA18804290
D008055LipidsBezafibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsFenofibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsGemfibrozil promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsGW 501516 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsLY 518674 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsBezafibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsFenofibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsGemfibrozil promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsGW 501516 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsLY 518674 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
D008055LipidsPPARA protein affects the reaction [Fenofibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids]]19201410
D008055LipidsPPARA protein affects the reaction [LY 518674 promotes the reaction [APOA1 protein results in increased secretion of Lipids]]19201410
D008055LipidsAPOA1 protein results in increased secretion of Lipids19201410
D008070LipopolysaccharidesAPOA1 protein inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]20972769
D008070LipopolysaccharidesAPOA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]20972769
D008070Lipopolysaccharides"APOA1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Cholesterol, HDL]"20972769
D008070LipopolysaccharidesAPOA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]20972769
D008070LipopolysaccharidesAPOA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TICAM1 mRNA]20972769
D008070LipopolysaccharidesAPOA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]20972769
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of APOA1 protein21474830
D008070LipopolysaccharidesLipopolysaccharides binds to APOA1 protein20972769
C558899lopinavir-ritonavir drug combinationlopinavir-ritonavir drug combination results in increased expression of APOA1 protein12646808
D008148Lovastatin[Lovastatin co-treated with Niacin] results in increased expression of APOA1 protein17319473
D008148Lovastatin[Niacin co-treated with Lovastatin] results in increased expression of APOA1 protein12633795
C479889LY 518674LY 518674 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
C479889LY 518674LY 518674 promotes the reaction [APOA1 protein results in increased secretion of Lipids]19201410
C479889LY 518674PPARA protein affects the reaction [LY 518674 promotes the reaction [APOA1 protein results in increased secretion of Lipids]]19201410
D008345ManganeseManganese results in increased expression of APOA1 mRNA18284614
D008383Margarine"[Margarine co-treated with Cholesterol, Dietary] results in decreased expression of APOA1 protein"15735083
C037500mastoparanmastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]16118212
C033266Menhaden oilMenhaden oil results in decreased expression of APOA1 mRNA7556148
D008610Menthol[Tobacco Smoke Pollution co-treated with Menthol] results in decreased expression of and results in decreased secretion of APOA1 protein27818348
C042720mercuric bromidemercuric bromide results in increased expression of APOA1 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA"27188386
D008627Mercuric ChlorideMercuric Chloride affects the expression of APOA1 mRNA20353558
D008627Mercuric ChlorideMercuric Chloride affects the expression of APOA1 protein21458406
D008748MethylcholanthreneMethylcholanthrene results in decreased expression of APOA1 mRNA18804290
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of APOA1 mRNA23179753
C043243methyl tert-butyl ethermethyl tert-butyl ether affects the expression of APOA1 mRNA24128854
C060893MK-886MK-886 inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA]19883121
C060893MK-886MK-886 results in decreased expression of APOA1 protein19883121
D009020MorphineMorphine results in increased expression of APOA1 protein23056601
C063509N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [APOA1 protein results in increased expression of APOE mRNA]22056562
C063509N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [APOA1 protein results in increased expression of CETP mRNA]22056562
C063509N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [APOA1 protein results in increased secretion of APOE protein]22056562
C063509N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [APOA1 protein results in increased secretion of CETP protein]22056562
C502028N-acetylleucyl-leucyl-norleucine"N-acetylleucyl-leucyl-norleucine inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C003297nandrolone decanoatenandrolone decanoate results in decreased expression of APOA1 protein16153628
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of APOA1"21654424
D019829NevirapineNevirapine results in increased expression of APOA1 protein19667106
D009525Niacin[Chromium co-treated with Niacin] results in increased expression of APOA1 mRNA18602814
D009525Niacin[Lovastatin co-treated with Niacin] results in increased expression of APOA1 protein17319473
D009525Niacin[Niacin co-treated with Ezetimibe co-treated with Simvastatin] results in increased expression of APOA1 protein20152243
D009525Niacin[Niacin co-treated with Lovastatin] results in increased expression of APOA1 protein12633795
D009525NiacinNiacin promotes the reaction [Rosuvastatin Calcium results in increased expression of APOA1 protein]12767421|1553996
D009525NiacinNiacin promotes the reaction [[Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein]18420099
D009525NiacinNiacin results in increased expression of APOA1 protein11701466|1276742
D009525Niacin2-chloro-5-nitrobenzanilide inhibits the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]19797938
D009525NiacinNiacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]19797938
D009525NiacinPPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]19797938
D009532NickelAPOA1 protein binds to Nickel23896426
D009532NickelNickel results in increased expression of APOA1 mRNA24084258
D009543NifedipineNifedipine results in increased expression of APOA11928808
C102148nitroaspirinnitroaspirin results in increased expression of APOA1 mRNA18519978
D005996NitroglycerinNitroglycerin results in decreased expression of APOA1 mRNA12102619
C002741N-nitrosomorpholineN-nitrosomorpholine affects the expression of APOA1 protein19716841
C464660obeticholic acidobeticholic acid results in decreased expression of APOA1 mRNA27939613
D019787Linoleic AcidLinoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D019787Linoleic AcidLinoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
D019787Linoleic AcidPLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]]16118212
D019301Oleic AcidOleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
D019301Oleic AcidOleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
C076029olanzapineolanzapine results in increased phosphorylation of APOA1 protein25821032
D009840OligomycinsOligomycins inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 protein]23227865
D009844Oligosaccharides[Oligosaccharides co-treated with Dietary Fats] results in increased expression of APOA1 protein28549616
D015525Fatty Acids, Omega-3"Fatty Acids, Omega-3 results in decreased expression of APOA1 mRNA"7556148
D010100OxygenOxygen deficiency results in increased expression of APOA1 mRNA18258771
C008757palmitoleic acidpalmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]16118212
C008757palmitoleic acidpalmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
D010278ParathionParathion results in increased methylation of APOA1 promoter22847954
C410127PCB 180PCB 180 affects the expression of APOA1 mRNA21703328
D004369Pentetic Acid"[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
D004369Pentetic Acid"Pentetic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]"12576517
C033094perfluorobutyric acidperfluorobutyric acid analog results in decreased expression of APOA1 mRNA21878386
C471071perfluorohexanesulfonic acidperfluorohexanesulfonic acid results in decreased expression of APOA1 mRNA21705711
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of APOA1 mRNA21705711
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of APOA1 protein26879310
C023036perfluorooctanoic acidperfluorooctanoic acid results in increased expression of APOA1 protein22609092
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of APOA1 mRNA17681415
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of APOA1 protein28126411
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of APOA1 mRNA18709148
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of APOA1 mRNA18804290
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of APOA1 mRNA19162173
C058216perilla seed oilperilla seed oil affects the expression of APOA1 protein10720173
D015232DinoprostoneDinoprostone inhibits the reaction [Carbon Tetrachloride results in increased expression of APOA1 mRNA]15816358
D010634PhenobarbitalPhenobarbital affects the expression of APOA1 protein16099942
D010634Phenobarbital[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOA1 protein20935162
D010634PhenobarbitalPhenobarbital results in increased expression of APOA1 mRNA11328961
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of APOA1 mRNA26272509
D010672PhenytoinPhenytoin results in increased expression of APOA1 mRNA15136057
D010716Phosphatidylinositols"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]"19013290
D010716Phosphatidylinositolsdioleoyl ethylene glycol inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716PhosphatidylinositolsGlycerol analog promotes the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716PhosphatidylinositolsMAPK1 protein affects the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716PhosphatidylinositolsMAPK3 protein affects the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716PhosphatidylinositolsPhosphatidylinositols results in decreased degradation of APOA1 protein19013290
D010716PhosphatidylinositolsPhosphatidylinositols results in increased expression of APOA1 protein19013290
D010716Phosphatidylinositolspyrazolanthrone inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716Phosphatidylinositolssulindac sulfide inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716Phosphatidylinositolstricyclodecane-9-yl-xanthogenate inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010716PhosphatidylinositolsU 0126 inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D010743PhospholipidsAPOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]16118212
D010743PhospholipidsArachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
D010743PhospholipidsLinoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
D010743PhospholipidsOleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
D010743Phospholipidspalmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]16118212
C060836pioglitazonepioglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
C060836pioglitazonepioglitazone results in increased secretion of APOA1 protein16530456
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]12595494
C006253pirinixic acid[pirinixic acid co-treated with SB 203580] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA]19883121
C006253pirinixic acid[pirinixic acid co-treated with U 0126] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA]19883121
C006253pirinixic acidpirinixic acid results in decreased expression of APOA1 mRNA7983038
C006253pirinixic acidpirinixic acid results in decreased expression of APOA1 protein19883121
C006253pirinixic acidpirinixic acid results in increased expression of APOA1 mRNA19883121
C006253pirinixic acidpirinixic acid results in increased expression of APOA1 protein19445040
C006253pirinixic acidpirinixic acid results in increased expression of APOA1 protein9869165
C006253pirinixic acid"Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]"16297877
C006253pirinixic acidginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]16297877
C006253pirinixic acidginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein]16297877
C006253pirinixic acidGinsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]16297877
C006253pirinixic acidGinsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein]16297877
C006253pirinixic acidpirinixic acid results in decreased expression of APOA1 mRNA16297877|2081375
C006253pirinixic acidpirinixic acid results in decreased expression of APOA1 protein16297877
C006253pirinixic acid"PPARA protein affects the reaction [Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]]"16297877
C006253pirinixic acidPPARA protein affects the reaction [ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]]16297877
C006253pirinixic acidPPARA protein affects the reaction [Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]]16297877
C006253pirinixic acidpirinixic acid affects the expression of APOA1 protein16099942
C006253pirinixic acidpirinixic acid results in decreased expression of APOA1 mRNA19162173
D028321Plant PreparationsPlant Preparations inhibits the reaction [Fructose results in decreased expression of APOA1 protein]27531227
D011137PolystyrenesPolystyrenes analog promotes the reaction [Simvastatin results in increased expression of APOA1 mRNA]8461338
D011137PolystyrenesPolystyrenes analog results in increased expression of APOA1 mRNA8461338
D011137PolystyrenesSimvastatin promotes the reaction [Polystyrenes analog results in increased expression of APOA1 mRNA]8461338
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of APOA1 protein23618972
D011192Potassium DichromatePotassium Dichromate affects the expression of APOA1 mRNA23608068
C009007potassium persulfatepotassium persulfate results in increased expression of APOA1 protein20815409
D017035PravastatinPravastatin results in decreased expression of APOA1 mRNA27225895
D017035PravastatinPravastatin results in increased expression of APOA1 mRNA27225895
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of APOA1 mRNA28903501
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of APOA1 mRNA19162173
D011341ProbucolProbucol inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
D011341ProbucolProbucol inhibits the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]]20083572
D011374ProgesteroneProgesterone results in increased expression of APOA1 mRNA20631399
C005556propionaldehydepropionaldehyde results in decreased expression of APOA1 mRNA26079696
D011441PropylthiouracilPropylthiouracil results in decreased expression of APOA1 mRNA24780913
C043680ptaquilosideptaquiloside results in decreased expression of APOA1 mRNA23274088
D011692Puromycin AminonucleosideAPOA1 protein results in decreased susceptibility to Puromycin Aminonucleoside7595070
D011692Puromycin AminonucleosidePuromycin Aminonucleoside results in increased expression of APOA1 mRNA7595070
D011692Puromycin AminonucleosidePuromycin Aminonucleoside results in increased expression of APOA1 mRNA7595070|8412754|
D011692Puromycin AminonucleosidePuromycin Aminonucleoside results in increased expression of APOA1 protein7066357|7442475|
D011718Pyrazinamide[Fenofibrate co-treated with Pyrazinamide] results in increased expression of APOA1 mRNA27071702
D011718PyrazinamidePyrazinamide results in increased expression of APOA1 mRNA27071702
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D011748PyrogallolPyrogallol results in increased expression of APOA1 mRNA20362636
D011794QuercetinESR1 protein affects the reaction [Quercetin results in increased secretion of APOA1 protein]24963805
D011794Quercetinfulvestrant inhibits the reaction [Quercetin results in increased secretion of APOA1 protein]24963805
D011794QuercetinQuercetin results in decreased expression of APOA1 mRNA25875015
D011794QuercetinQuercetin results in increased expression of APOA1 mRNA24963805
D011794QuercetinQuercetin results in increased secretion of APOA1 protein24963805
D011794Quercetin[Glutathione co-treated with Quercetin] promotes the reaction [APOA1 protein results in increased export of Cholesterol]25204422
D011794QuercetinQuercetin promotes the reaction [APOA1 protein results in increased export of Cholesterol]25204422
C059514resveratrol"resveratrol inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C059514resveratrolresveratrol inhibits the reaction [APOA1 protein results in increased export of Cholesterol]23041272
C059514resveratrolresveratrol inhibits the reaction [Dietary Fats results in decreased expression of APOA1 protein]18166149
D000068718Rosuvastatin CalciumNiacin promotes the reaction [Rosuvastatin Calcium results in increased expression of APOA1 protein]12767421|1553996
D000068718Rosuvastatin CalciumRosuvastatin Calcium results in increased expression of APOA1 protein12767421|1553996
C550378RVX 208RVX 208 results in increased expression of APOA1 protein25278768
D012450Safflower OilSafflower Oil affects the expression of APOA1 protein10720173
D012459SalicylatesSalicylates results in increased expression of APOA1 mRNA18519978
D012524SarinSarin results in decreased expression of APOA1 protein26778279
C093642SB 203580[pirinixic acid co-treated with SB 203580] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA]19883121
D019821SimvastatinHomocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 mRNA]18540024
D019821SimvastatinHomocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 protein]18540024
D019821Simvastatin[Niacin co-treated with Ezetimibe co-treated with Simvastatin] results in increased expression of APOA1 protein20152243
D019821SimvastatinNiacin promotes the reaction [[Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein]18420099
D019821Simvastatin[Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein18420099
D019821SimvastatinSimvastatin results in increased expression of and results in increased secretion of APOA1 protein12048122
D019821SimvastatinSimvastatin results in increased expression of APOA1 mRNA12048122|1827045
D019821SimvastatinSimvastatin results in increased expression of APOA1 protein12633795|1827045
D019821SimvastatinSimvastatin results in increased expression of and results in increased secretion of APOA1 protein12048122
D019821SimvastatinSimvastatin results in increased expression of APOA1 mRNA12048122
D019821SimvastatinMTHFR gene mutant form inhibits the reaction [Simvastatin results in increased expression of APOA1 protein]18540024
D019821SimvastatinSimvastatin results in increased expression of APOA1 mRNA21241519
D019821SimvastatinSimvastatin results in increased expression of APOA1 protein18540024|2124151
D019821SimvastatinPolystyrenes analog promotes the reaction [Simvastatin results in increased expression of APOA1 mRNA]8461338
D019821SimvastatinSimvastatin promotes the reaction [Polystyrenes analog results in increased expression of APOA1 mRNA]8461338
D019821SimvastatinSimvastatin results in decreased expression of APOA1 mRNA25055962
D019821SimvastatinSimvastatin results in decreased expression of APOA1 protein8289597|8461338
D019821SimvastatinSimvastatin results in increased expression of APOA1 mRNA8461338
C017947sodium arsenitesodium arsenite affects the methylation of APOA1 gene28589171
C017947sodium arsenitesodium arsenite results in decreased expression of APOA1 mRNA17450228
D012969Sodium FluorideSodium Fluoride results in increased expression of APOA1 protein28918527
D018038Sodium SeleniteSodium Selenite results in decreased expression of APOA1 mRNA23274088
D013024Soybean Oil"[Soybean Oil co-treated with Cholesterol, Dietary] results in decreased expression of APOA1 protein"15735083
D013311StreptozocinStreptozocin results in increased expression of APOA1 protein19634143
D013311StreptozocinTrientine inhibits the reaction [Streptozocin results in increased expression of APOA1 protein]19634143
C025462sulindac sulfidesulindac sulfide inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D014284TriiodothyronineTriiodothyronine results in increased expression of APOA1 protein6816881
D013629TamoxifenTamoxifen results in increased expression of APOA1 mRNA16835292
D013656Taurocholic AcidTaurocholic Acid results in decreased expression of APOA1 protein19445040
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid results in decreased expression of APOA1 mRNA15885361
C003377taxifolintaxifolin results in increased expression of APOA1 protein11108730
C012568terbufosterbufos results in increased methylation of APOA1 promoter22847954
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of APOA1 mRNA26377647
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOA1 mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of APOA1 mRNA15800033|2297716
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of APOA1 mRNA15703262
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of APOA1 mRNA16267337
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of APOA1 mRNA15644576|1649779
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of APOA1 protein16497791
C096900thrombin receptor-activating peptide SFLLRNPNDKYthrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of APOA1 protein17303692
C423915TO-901317"TO-901317 inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein]"19717637
C423915TO-901317TO-901317 inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA]19883121
C423915TO-901317TO-901317 results in decreased expression of APOA1 protein19883121
C423915TO-901317[TO-901317 co-treated with APOA1 protein] results in increased secretion of Cholesterol20083572
C423915TO-901317TO-901317 promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]20083572
C423915TO-901317TO-901317 promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
C423915TO-901317TO-901317 results in increased expression of APOA1 mRNA16530456
C423915TO-901317TO-901317 results in increased secretion of APOA1 protein16530456
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased expression of APOA1 protein19478969
D014028Tobacco Smoke Pollution[Tobacco Smoke Pollution co-treated with Menthol] results in decreased expression of and results in decreased secretion of APOA1 protein27818348
C066340tolcaponetolcapone binds to APOA1 protein19783845
D014108Tosylphenylalanyl Chloromethyl KetoneTosylphenylalanyl Chloromethyl Ketone promotes the reaction [APOA1 protein results in increased expression of APOE mRNA]22056562
D014108Tosylphenylalanyl Chloromethyl KetoneTosylphenylalanyl Chloromethyl Ketone promotes the reaction [APOA1 protein results in increased expression of CETP mRNA]22056562
D014108Tosylphenylalanyl Chloromethyl KetoneTosylphenylalanyl Chloromethyl Ketone promotes the reaction [APOA1 protein results in increased secretion of APOE protein]22056562
D014108Tosylphenylalanyl Chloromethyl KetoneTosylphenylalanyl Chloromethyl Ketone promotes the reaction [APOA1 protein results in increased secretion of CETP protein]22056562
D014204Trenbolone AcetateTrenbolone Acetate results in decreased expression of APOA1 mRNA25198161
D014212Tretinoin[fenofibric acid co-treated with Tretinoin] results in increased expression of APOA1 mRNA7556148
D014212Tretinoinfenofibric acid inhibits the reaction [Tretinoin results in increased expression of APOA1 mRNA]7556148
D014212TretinoinTretinoin results in increased expression of APOA1 mRNA7556148
C046498tricyclodecane-9-yl-xanthogenatetricyclodecane-9-yl-xanthogenate inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D014266TrientineTrientine inhibits the reaction [Streptozocin results in increased expression of APOA1 protein]19634143
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of APOA1 mRNA"26179874
C057693troglitazonetroglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol]16530456
C057693troglitazonetroglitazone results in decreased expression of APOA1 mRNA16530456
C057693troglitazonetroglitazone results in increased secretion of APOA1 protein16530456
C113580U 0126[pirinixic acid co-treated with U 0126] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA]19883121
C113580U 0126U 0126 inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]19013290
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid results in increased expression of APOA1 mRNA15115973
D014635Valproic AcidValproic Acid affects the expression of APOA1 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of APOA1 mRNA23179753|2718838
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of APOA1 gene25560391
D014810Vitamin EVitamin E results in increased expression of APOA1 protein18458655
D024483Vitamin K 3Vitamin K 3 affects the expression of APOA1 mRNA20829426
D015032ZincAPOA1 protein binds to Zinc23896426
D015032ZincZinc deficiency results in decreased expression of APOA1 mRNA12107072
D015032ZincZinc results in decreased expression of APOA1 protein12679171
D015032ZincZinc results in increased expression of APOA1 mRNA12107072

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0001540amyloid-beta binding-IDA11297421  
GO:0001540amyloid-beta binding-IPI9211985  
GO:0005515protein binding-IPI1587806  11297421  11991719  12084722  12917409  15174051  
17676061  17786215  19758344  25241761  25416956  25910212  
GO:0005543phospholipid binding-IBA21873635  
GO:0005543phospholipid binding-IDA12810715  
GO:0005548phospholipid transporter activity-IEA-  
GO:0008035high-density lipoprotein particle binding-IEA-  
GO:0015485cholesterol binding-IBA21873635  
GO:0015485cholesterol binding-IDA15464323  
GO:0017127cholesterol transporter activity-IBA21873635  
GO:0017127cholesterol transporter activitycontributes_toIDA9651324  
GO:0017127cholesterol transporter activity-IMP15464323  
GO:0019899enzyme binding-IPI1587806  
GO:0031072heat shock protein binding-IPI11027668  
GO:0034190apolipoprotein receptor binding-IPI11162594  
GO:0034191apolipoprotein A-I receptor binding-IPI16443932  
GO:0042802identical protein binding-IPI8049247  17676061  18719128  20133843  22609356  24316228  
24702826  
GO:0045499chemorepellent activity-IDA23726972  
GO:0055102lipase inhibitor activity-IEA-  
GO:0060228phosphatidylcholine-sterol O-acyltransferase activator activity-IBA21873635  
GO:0060228phosphatidylcholine-sterol O-acyltransferase activator activity-IDA4335615  
GO:0070653high-density lipoprotein particle receptor binding-IBA21873635  
GO:0070653high-density lipoprotein particle receptor binding-IPI10764676  12651854  
GO ID GO Term Qualifier Evidence PubMed
GO:0001523retinoid metabolic process-TAS-  
GO:0001932regulation of protein phosphorylation-IEA-  
GO:0001935endothelial cell proliferation-IEA-  
GO:0002576platelet degranulation-TAS-  
GO:0002740negative regulation of cytokine secretion involved in immune response-IDA12458630  
GO:0006656phosphatidylcholine biosynthetic process-IDA4335615  
GO:0006695cholesterol biosynthetic process-IBA21873635  
GO:0006898receptor-mediated endocytosis-TAS-  
GO:0007179transforming growth factor beta receptor signaling pathwayNOTIDA23726972  
GO:0007186G-protein coupled receptor signaling pathway-IDA16443932  
GO:0007229integrin-mediated signaling pathway-IDA23726972  
GO:0007584response to nutrient-IEA-  
GO:0008203cholesterol metabolic process-IMP15464323  
GO:0008211glucocorticoid metabolic process-IEA-  
GO:0010804negative regulation of tumor necrosis factor-mediated signaling pathway-IDA21571275  
GO:0010873positive regulation of cholesterol esterification-IBA21873635  
GO:0010873positive regulation of cholesterol esterification-IDA4335615  
GO:0010903negative regulation of very-low-density lipoprotein particle remodeling-IDA14967812  
GO:0014012peripheral nervous system axon regeneration-IEA-  
GO:0018158protein oxidation-IDA12576517  
GO:0018206peptidyl-methionine modification-IDA12576517  
GO:0019216regulation of lipid metabolic process-TAS-  
GO:0019433triglyceride catabolic process-IBA21873635  
GO:0019915lipid storage-IEA-  
GO:0030301cholesterol transport-IDA10559507  
GO:0030325adrenal gland development-IEA-  
GO:0031100animal organ regeneration-IEA-  
GO:0031102neuron projection regeneration-IBA21873635  
GO:0032374regulation of cholesterol transport-IBA21873635  
GO:0032489regulation of Cdc42 protein signal transduction-IDA16443932  
GO:0033344cholesterol efflux-IBA21873635  
GO:0033344cholesterol efflux-IDA11162594  14703508  15358760  16443932  21481393  
GO:0033344cholesterol efflux-IMP12202492  
GO:0033700phospholipid efflux-IBA21873635  
GO:0033700phospholipid efflux-IDA11162594  14703508  
GO:0034115negative regulation of heterotypic cell-cell adhesion-IDA21571275  
GO:0034371chylomicron remodeling-TAS-  
GO:0034372very-low-density lipoprotein particle remodeling-IBA21873635  
GO:0034375high-density lipoprotein particle remodeling-IC4335615  
GO:0034375high-density lipoprotein particle remodeling-IDA21481393  
GO:0034375high-density lipoprotein particle remodeling-TAS-  
GO:0034378chylomicron assembly-TAS-  
GO:0034380high-density lipoprotein particle assembly-IBA21873635  
GO:0034380high-density lipoprotein particle assembly-IDA190223  
GO:0034380high-density lipoprotein particle assembly-TAS-  
GO:0034384high-density lipoprotein particle clearance-IC12651854  
GO:0034384high-density lipoprotein particle clearance-TAS-  
GO:0035025positive regulation of Rho protein signal transduction-IDA23726972  
GO:0042157lipoprotein metabolic process-IBA21873635  
GO:0042158lipoprotein biosynthetic process-IEA-  
GO:0042493response to drug-IEA-  
GO:0042632cholesterol homeostasis-IBA21873635  
GO:0042632cholesterol homeostasis-IDA21571275  
GO:0042632cholesterol homeostasis-IMP15464323  
GO:0043534blood vessel endothelial cell migration-IEA-  
GO:0043627response to estrogen-IEA-  
GO:0043687post-translational protein modification-TAS-  
GO:0043691reverse cholesterol transport-IBA21873635  
GO:0043691reverse cholesterol transport-IMP15464323  
GO:0044267cellular protein metabolic process-TAS-  
GO:0046889positive regulation of lipid biosynthetic process-IBA21873635  
GO:0050713negative regulation of interleukin-1 beta secretion-IDA12458630  
GO:0050728negative regulation of inflammatory response-IDA21571275  
GO:0050821protein stabilization-IDA17655203  
GO:0050919negative chemotaxis-IDA23726972  
GO:0051180vitamin transport-IMP15140193  
GO:0051345positive regulation of hydrolase activity-IDA7638166  
GO:0051496positive regulation of stress fiber assembly-IDA23726972  
GO:0055091phospholipid homeostasis-IDA21571275  
GO:0060192negative regulation of lipase activity-IEA-  
GO:0060354negative regulation of cell adhesion molecule production-IDA21571275  
GO:0060761negative regulation of response to cytokine stimulus-IDA21571275  
GO:0070328triglyceride homeostasis-IDA21571275  
GO:0070371ERK1 and ERK2 cascadeNOTIDA23726972  
GO:0070508cholesterol import-IMP14718538  
GO:1900026positive regulation of substrate adhesion-dependent cell spreading-IDA23726972  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-HDA27068509  
GO:0005576extracellular region-TAS-  
GO:0005615extracellular space-HDA16502470  20551380  22664934  
GO:0005615extracellular space-IDA19433579  
GO:0005615extracellular space-ISS22261194  
GO:0005634nucleus-IEA-  
GO:0005769early endosome-TAS-  
GO:0005788endoplasmic reticulum lumen-TAS-  
GO:0005829cytosol-TAS-  
GO:0005886plasma membrane-TAS-  
GO:0009986cell surface-IEA-  
GO:0030139endocytic vesicle-IDA14747463  
GO:0031410cytoplasmic vesicle-IDA14703508  
GO:0034361very-low-density lipoprotein particle-IDA17154273  
GO:0034362low-density lipoprotein particle-IEA-  
GO:0034363intermediate-density lipoprotein particle-IEA-  
GO:0034364high-density lipoprotein particle-IBA21873635  
GO:0034364high-density lipoprotein particle-IDA210174  3104518  9211985  15464323  21571275  
GO:0034365discoidal high-density lipoprotein particle-IEA-  
GO:0034366spherical high-density lipoprotein particle-IDA16682745  
GO:0034774secretory granule lumen-TAS-  
GO:0042627chylomicron-IBA21873635  
GO:0062023collagen-containing extracellular matrix-HDA27559042  
GO:0070062extracellular exosome-HDA19056867  19199708  23533145  
GO:0071682endocytic vesicle lumen-TAS-  
GO:0072562blood microparticle-HDA22516433  
GO:1903561extracellular vesicle-HDA24769233  
KEGG ID KEGG Term
hsa03320PPAR signaling pathway
hsa04975Fat digestion and absorption
hsa04977Vitamin digestion and absorption
hsa05143African trypanosomiasis
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-114608Platelet degranulation TAS
R-HSA-1369062ABC transporters in lipid homeostasisTAS
R-HSA-1430728MetabolismTAS
R-HSA-1430728MetabolismIEA
R-HSA-162582Signal TransductionTAS
R-HSA-162582Signal TransductionIEA
R-HSA-174824Plasma lipoprotein assembly, remodeling, and clearanceTAS
R-HSA-196854Metabolism of vitamins and cofactorsTAS
R-HSA-196854Metabolism of vitamins and cofactorsIEA
R-HSA-1989781PPARA activates gene expressionTAS
R-HSA-2168880Scavenging of heme from plasmaTAS
R-HSA-2173782Binding and Uptake of Ligands by Scavenger ReceptorsIEA
R-HSA-2173782Binding and Uptake of Ligands by Scavenger ReceptorsTAS
R-HSA-2187338Visual phototransductionTAS
R-HSA-2187338Visual phototransductionIEA
R-HSA-3000471Scavenging by Class B ReceptorsIEA
R-HSA-3000471Scavenging by Class B ReceptorsTAS
R-HSA-3000480Scavenging by Class A ReceptorsIEA
R-HSA-3000480Scavenging by Class A ReceptorsTAS
R-HSA-372790Signaling by GPCRTAS
R-HSA-372790Signaling by GPCRIEA
R-HSA-381426Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)TAS
R-HSA-382551Transport of small moleculesTAS
R-HSA-382556ABC-family proteins mediated transportTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-388396GPCR downstream signallingIEA
R-HSA-392499Metabolism of proteinsTAS
R-HSA-400206Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)TAS
R-HSA-418594G alpha (i) signalling eventsTAS
R-HSA-418594G alpha (i) signalling eventsIEA
R-HSA-556833Metabolism of lipidsTAS
R-HSA-5653656Vesicle-mediated transportIEA
R-HSA-5653656Vesicle-mediated transportTAS
R-HSA-597592Post-translational protein modificationTAS
R-HSA-6806667Metabolism of fat-soluble vitaminsTAS
R-HSA-6806667Metabolism of fat-soluble vitaminsIEA
R-HSA-76002Platelet activation, signaling and aggregationTAS
R-HSA-76005Response to elevated platelet cytosolic Ca2+TAS
R-HSA-8957275Post-translational protein phosphorylationTAS
R-HSA-8963888Chylomicron assemblyTAS
R-HSA-8963896HDL assemblyTAS
R-HSA-8963898Plasma lipoprotein assemblyTAS
R-HSA-8963899Plasma lipoprotein remodelingTAS
R-HSA-8963901Chylomicron remodelingTAS
R-HSA-8964011HDL clearanceTAS
R-HSA-8964043Plasma lipoprotein clearanceTAS
R-HSA-8964058HDL remodelingTAS
R-HSA-975634Retinoid metabolism and transportTAS
R-HSA-975634Retinoid metabolism and transportIEA
R-HSA-977225Amyloid fiber formationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
18079094[Risk status of patients with peripheral arterial disease (PAD)]. (2007 Dec 30)Jasso IOrv Hetil
15364185Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (2004 Sep 11-17)Yusuf SLancet
20538481Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects. (2010 Nov-Dec)Kostapanos MSJ Stroke Cerebrovasc Dis
16372134Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels. (2006)Katzov HJ Hum Genet
15646744[Interheart: nine risk factors predict nine out of ten myocardial infarctions]. (2004 Nov)Scheen AJRev Med Liege
7695175Detection and treatment of elevated blood lipids and other risk factors for coronary artery disease in youth. (1995 Jan 17)Kwiterovich PO JrAnn N Y Acad Sci
20362293High levels of soluble intercellular adhesion molecule-1, insulin resistance and saturated fatty acids are associated with endothelial dysfunction in healthy adolescents. (2010 Aug)Chen YAtherosclerosis
29758034Interactions among genes involved in reverse cholesterol transport and in the response to environmental factors in dyslipidemia in subjects from the Xinjiang rural area. (2018)Wang XPLoS One
23125402Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. (2014 Apr)Gehani AAEur J Prev Cardiol
9878681Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus. (1999 Jan)Sankaranarayanan KMutat Res
7569454[Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl]. (1995 Feb)Arteaga ARev Med Chil
10073983Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. (1999 Mar)Rainwater DLArterioscler Thromb Vasc Biol
23645505Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies. (2013 May)Leon DAEur J Epidemiol
2128269[Serum apolipoprotein AI, B levels in patients with coronary diseases]. (1990 Aug)He YZhonghua Xin Xue Guan Bing Za Zhi
18277343ApoB/ApoA1 ratio and subclinical atherosclerosis. (2008 Feb)Panayiotou AInt Angiol
25672030Novel atherosclerotic risk factors and angiographic profile of young Gujarati patients with acute coronary syndrome. (2014 Jul)Prajapati JJ Assoc Physicians India
28332615Integrative variants, haplotypes and diplotypes of the CAPN3 and FRMD5 genes and several environmental exposures associate with serum lipid variables. (2017 Mar 23)Guo TSci Rep
10780336Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study. (2000 Jan)Chu NFEur J Epidemiol
26306861Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects. (2015 Oct 14)Titz BJ Proteomics
8364758[Justification and imperatives of the campaign against excess cholesterol and prevention of atherosclerosis]. (1993 Apr)de Gennes JLBull Acad Natl Med
25428744Correlation of lipid parameters and markers of insulin resistance: does smoking make a difference? (2014)Cibickova LPhysiol Res
23758630Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population. (2013 Jun 8)Lu YLipids Health Dis
21743088Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study. (2011 Oct)Ajeganova SRheumatology (Oxford)
8785232Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis. (1995 Oct-Dec)Siamopoulos KCPerit Dial Int
26759540The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years. (2015 Oct)Owczarczyk-Saczonek ABPostepy Dermatol Alergol
20964824Lower paraoxonase 1 activity in Tunisian bipolar I patients. (2010 Oct 21)Ezzaher AAnn Gen Psychiatry
20442857Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study. (2010 Apr 29)Suchindran SPLoS Genet
9481602Relationship between anthropometric variables and lipid levels among school children: The Taipei Children Heart Study. (1998 Jan)Chu NFInt J Obes Relat Metab Disord
24051266Clusters of AMI risk factors and their association with left ventricular hypertrophy: a population-based study within the Skaraborg Project, Sweden. (2013 Oct 15)Larsson CAInt J Cardiol
22693160Circulating oxidised LDL lipids, when proportioned to HDL-c, emerged as a risk factor of all-cause mortality in a population-based survival study. (2013 Jan)Linna MAge Ageing
28038449Low serum paraoxonase1 activity levels predict coronary artery disease severity. (2017 Mar 21)Sun TOncotarget
22048271Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease. (2011)Huang YDis Markers
24228807Associations between smoking, components of metabolic syndrome and lipoprotein particle size. (2013 Sep 3)Slagter SNBMC Med
22167477Parental influences on cardiovascular risk factors in Swedish children aged 5-14 years. (2012 Dec)Khanolkar AREur J Public Health
24801236Effect of maternal lipid profile, C-peptide, insulin, and HBA1c levels during late pregnancy on large-for-gestational age newborns. (2014 May)Hou RLWorld J Pediatr
24376512Gene-gene combination effect and interactions among ABCA1, APOA1, SR-B1, and CETP polymorphisms for serum high-density lipoprotein-cholesterol in the Japanese population. (2013)Nakamura APLoS One
23183507The Czech ABI Project - prevalence of peripheral arterial disease in patients at risk using the ankle-brachial index in general practice (a cross-sectional study). (2012)Karetova DNeuro Endocrinol Lett
7500552[Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis]. (1995 Jul)Ishikawa YNihon Ronen Igakkai Zasshi
24879358Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity. (2015 Jul)Hellgren MIEur J Prev Cardiol
19350521[Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease]. (2009 Apr)Wei MZhonghua Yi Xue Yi Chuan Xue Za Zhi
28774484Cardiovascular disease risk associated with serum apolipoprotein B is modified by serum vitamin A. (2017 Oct)Olsen TAtherosclerosis
20348046[Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers]. (2010 Mar-Apr)Haj Mouhamed DAnn Biol Clin (Paris)
27431356Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. (2016 Aug 20)O'Donnell MJLancet
21692678Cardiovascular disease risk factors in homeless people. (2011 Aug)Kaldmae MUps J Med Sci
21458815Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease. (2011 Jul)Toyama KAtherosclerosis
18476573[Study on the relationship between passive smoking and blood lipids, fibrinogen and viscosity among women who never smoke]. (2007 Dec)He YZhonghua Liu Xing Bing Xue Za Zhi
28595104Pre-beta1 HDL in type 2 diabetes mellitus. (2017 Aug)Shiu SWAtherosclerosis
26824674Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome. (2016)Wu YPLoS One
25656165Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk. (2015 Mar)Xie XTissue Antigens
22088246[Clinical and angiographic characteristics of patients with slow coronary flow]. (2011 Jul)Dai YXZhonghua Xin Xue Guan Bing Za Zhi
11887026Circulating oxidized LDL is associated with increased levels of cell-adhesion molecules in clinically healthy 58-year old men (AIR study). (2002 Mar)Hulthe JMed Sci Monit
9125316Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. (1996 Dec 20)Kamboh MIAtherosclerosis
19648057A comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbo study of Australian elderly. (2009 Oct)Simons LAHeart Lung Circ
25620253[Association between apolipoprotein A1-75 bp gene polymorphisms and risk for dyslipidemia and coronary artery disease]. (2014 Nov)Wei XZhonghua Xin Xue Guan Bing Za Zhi
28031419Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study. (2017 Mar)Brahimaj ADiabetes Care
28072742The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes. (2017 Jan)Mao YMedicine (Baltimore)
21589926Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks. (2011 May 11)Turner SDPLoS One
26573599Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skovde Cohort. (2015 Nov 14)Daka BBMC Cardiovasc Disord
27169840Risk factors, topographic patterns and mechanism analysis of intracranial atherosclerotic stenosis ischemic stroke. (2017 Mar)Wang YInt J Neurosci
19476111Retrospective analysis of risk factors in young patients with coronary artery disease in Guangdong and Zhejiang, China. (2009 Apr)Fang CActa Cardiol
28666478Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study. (2017 Jun 30)Kokkonen HArthritis Res Ther
14985310Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. (2004 Mar)Lyons TJInvest Ophthalmol Vis Sci
26086425Attenuation of Cigarette Smoke-Induced Emphysema in Mice by Apolipoprotein A-1 Overexpression. (2016 Jan)Kim CAm J Respir Cell Mol Biol
15488874A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men. (2004 Nov)Liu SAtherosclerosis
8835402Lipoprotein composition and serum cholesterol ester fatty acids in nonwesternized Melanesians. (1996 Feb)Lindeberg SLipids
24895480Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men. (2014 May)Parlesak AJ Clin Biochem Nutr
21960651Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study. (2012 Dec)Koskinen JEur J Prev Cardiol
9241743Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. (1997 Jun)Gardemann AThromb Haemost
17587723Sex difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients. (2007 Jul)Tseng CHCirc J
28128572[Genetic determination of dyslipidemia - What tell us the results of genome-wide association studies?] (Fall 2016)Hubacek JAVnitr Lek
24863406Sleep duration and abnormal serum lipids: the China Health and Nutrition Survey. (2014 Jul)Zhan YSleep Med
23183508HDL and apolipoprotein A1 concentrations as markers of cholesterol efflux in middle-aged women: interaction with smoking. (2012)Kralova Lesna INeuro Endocrinol Lett
25932792Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol. (2015 Jun)Savinova OVAtherosclerosis
21244559Lipoprotein(a) identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort Study. (2011 May)Cunningham TEJ Paediatr Child Health
23055759The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults. (2012)Da Costa LADiabetes Metab Syndr Obes
24813034Paraoxonase 1 activity and lipid profile in schizophrenic patients. (2014 Jun)Mabrouk HAsian J Psychiatr